Idexx Laboratories Inc
IDXX Real Time Price USDRecent trades of IDXX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in IDXX holdings by institutional investors
Quarterly net insider trading by IDXX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
IDXX Estimated quarterly lobbying spending
IDXX Revenue by Segment or Geography
New IDXX patent grants
-
Patent Title: Reagent consumable tube Nov. 04, 2025
-
Patent Title: Display screen or portion thereof with a graphical user interface for reporting medical data Apr. 29, 2025
-
Patent Title: Display screen or portion thereof with graphical user interface for viewing x-ray images and calculating vertebral heart score Apr. 01, 2025
-
Patent Title: Container Apr. 07, 2020
-
Patent Title: Container Mar. 31, 2020
-
Patent Title: Container Mar. 03, 2020
-
Patent Title: Container Mar. 03, 2020
-
Patent Title: Methods for detecting symmetrical dimethylarginine May. 15, 2018
-
Patent Title: Immunoassay test slide Apr. 03, 2018
-
Patent Title: Chemical analyzer Nov. 21, 2017
-
Patent Title: Chemical analyzer Oct. 24, 2017
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm Aug. 29, 2017
-
Patent Title: Method and device for detecting bacteria and determining the concentration thereof in a liquid sample May. 09, 2017
-
Patent Title: Method for calibrating clinical chemistry instruments Sep. 27, 2016
-
Patent Title: Detection of analytes present in exosomes May. 31, 2016
-
Patent Title: Compositions, devices, kits and methods for detecting hookworm Jan. 19, 2016
-
Patent Title: Canine anti-cd20 antibodies Jan. 05, 2016
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm Dec. 15, 2015
-
Patent Title: Automated calibration method and system for a diagnostic analyzer Oct. 06, 2015
-
Patent Title: Fluid pressure control device for an analyzer Oct. 06, 2015
-
Patent Title: Compositions and methods for detection of antibodies specific for Sep. 01, 2015
-
Patent Title: Chemical analyzer Aug. 25, 2015
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm Aug. 11, 2015
-
Patent Title: Methods for detecting symmetrical dimethylarginine Jul. 28, 2015
-
Patent Title: Device, kit and method for hookworm antigen capture and detection Jun. 23, 2015
-
Patent Title: Sample collection and analysis May. 26, 2015
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm May. 26, 2015
-
Patent Title: Fluoroquinolone compositions Apr. 21, 2015
-
Patent Title: Method for calibrating clinical chemistry instruments Feb. 03, 2015
-
Patent Title: Sample collection and analysis Feb. 03, 2015
-
Patent Title: Sample collection and analysis Jan. 06, 2015
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm Nov. 25, 2014
-
Patent Title: Methods and systems for creating and utilizing a field structure Sep. 09, 2014
-
Patent Title: Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds Sep. 09, 2014
-
Patent Title: Detection of feline immunodeficiency virus Aug. 19, 2014
-
Patent Title: Detection of degradation products of canine nt-probnp Jul. 15, 2014
-
Patent Title: Method of normalizing a fluorescence analyzer Jun. 24, 2014
-
Patent Title: Automated calibration method and system for a diagnostic analyzer Feb. 04, 2014
-
Patent Title: Retaining clip for reagent test slides Nov. 19, 2013
-
Patent Title: Proboscis for use with a diagnostic instrument Nov. 19, 2013
-
Patent Title: Method and system for representation of current and historical medical data Nov. 19, 2013
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm Nov. 12, 2013
-
Patent Title: Compositions and methods for detection of antibodies specific for Nov. 12, 2013
-
Patent Title: Method and system for representation of current and historical medical data Nov. 12, 2013
-
Patent Title: Methods for detecting symmetrical dimethylarginine Jul. 09, 2013
-
Patent Title: Detection of degradation products of feline nt-probnp Jul. 09, 2013
-
Patent Title: Methods and compositions for detection of Apr. 02, 2013
-
Patent Title: Lateral flow device May. 29, 2012
-
Patent Title: Lateral flow device May. 29, 2012
-
Patent Title: Consumable tube for use with a flow cytometry-based hematology system Feb. 15, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded to IDXX from public contracts
Recent insights relating to IDXX
Recent picks made for IDXX stock on CNBC
ETFs with the largest estimated holdings in IDXX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $IDXX stock a Buy, Sell, or Hold?
- What is the price target for $IDXX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $IDXX stock?
- Who owns the most shares of $IDXX stock?
- What funds own $IDXX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IDXX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
- Address Westbrook, ME
- Market Cap 58.0 billion
- Employees 11,000
- Industrial Classification In Vitro & In Vivo Diagnostic Substances